Novaerus

Chicago, United States Founded: 2011 • Age: 15 yrs
Airborne pathogens are neutralized using plasma field technology.

About Novaerus

Novaerus is a Healthcare company based in Chicago (United States) founded in 2011. Airborne pathogens are neutralized using plasma field technology. Novaerus has raised $25 million across 2 funding rounds from investors including Polaris Partners and F-Prime Capital. The company has 19 employees. Novaerus has completed 1 acquisition, including Plasma Air. Novaerus offers products and services including Defend 400 and Defend 1050. Its focus areas include Life Sciences, Hospital Equipment, Hospital Infection Control and Air Sanitization. Its legal entity is Novaerus, Inc.

Company details

Novaerus is a company that offers an airborne pathogen control technology to help improve quality of air. Novaerus scrubs the air using a unique plasma field to reduce airborne pathogens. Novaerus claims its clients can expect lowered re-hospitalizations and decreased antibiotic usage within one year of implementing the Novaerus technology. The technology eradicates all airborne viruses,bacteria, moulds and odours and destroys contaminants like MRSA, C-Diff, Norovirus and Influenza.

Key Metrics
  • Total Equity Funding
    $25M (USD)

    in 2 rounds

  • Latest Funding Round
    $15M (USD), Series B

    Feb 2016

  • Investors
  • Employee Count
    19
  • Investments & Acquisitions

Products & Services of Novaerus

Novaerus offers a comprehensive portfolio of products and services, including Defend 400 and Defend 1050.

Defend 400
Air Disinfection Device

Inactivates viruses and purifies air in medium to large spaces.

Defend 1050
Air Disinfection Device

Provides rapid remediation for large, high-risk environments.

Funding Insights of Novaerus

Novaerus has successfully raised a total of $25M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $15 million completed in February 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $25M
  • Total Rounds 2
  • Last Round Series B β€” $15M
  • First Round $10M

    (Nov 2014)

  • Investors Count 2

All 2 funding rounds of Novaerus with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Feb 2016$15MSeries B––
Nov 2014$10MSeries A––
Valuation history

2 investors in total: 2 institutional.

Investors in Novaerus

Novaerus has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Polaris Partners and F-Prime Capital.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
US focused venture capital firm
polarispartners.comBoston, United States
Investments in life sciences, technology, healthtech, and crypto sectors from global locations.
fprimecapital.com
Premium access

Investor details for Novaerus

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Novaerus

4 people are tracked at Novaerus (4 in board & advisors); the tracked headcount is 19.

NameRoleGroup
Thomas Caranasos
Medical Board MemberBoard & advisors
Regina Benjamin
Medical Board ChairBoard & advisors
David J. Weber
Medical Board MemberBoard & advisors
Daniel E. Dawes
Medical Board MemberBoard & advisors
Premium access

Complete people profiles for Novaerus

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Novaerus

Novaerus has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Plasma Air.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Air purification systems for buildings are manufactured using bipolar ionization.
plasma-air.com0Jun 2016β€’β€’β€’β€’
Premium access

Complete acquisition details for Novaerus

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Novaerus

4 dated milestones of Novaerus across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded Novaerus is founded.
  2. Funding First funding round of $10.0M.
  3. Funding Latest funding round, Series B, of $15.0M.
  4. Acquisition Acquires Plasma Air.

Web traffic of Novaerus

Websites that share an audience with Novaerus (novaerus.com).

Similar websites

Websites whose visitors overlap most with Novaerus. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
conditions.healthguru.com
conditions.healthguru.com
100%
–
everydayhealth.com
52%
5.4M#13,496View details

Top companies in Medical Equipment & Supplies

3 companies that operate in the same segment as Novaerus (Medical Equipment & Supplies) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Robotic waterjet system for prostate tissue removal is developed.
2009Redwood City, California, United StatesUSD 348.84 MUSD 308.05 M756
Robotic microsurgical systems for endoscopy are developed.
2007Redwood City, California, United StatesUSD 733.62 M91
Injectable packaging, containment, and delivery solutions are manufactured.
1923Exton, Pennsylvania, United StatesUSD 8.15 B6,357
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Novaerus

Premium access

Complete news archive for Novaerus

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Novaerus

Novaerus was founded in 2011 and raised its 1st funding round 3 years after it was founded.

Novaerus is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.

Novaerus is a funded company, having raised a total of $25M across 2 funding rounds to date. The company's 1st funding round was a Series A of $10M, raised on Nov 2014.

Novaerus has 19 employees.

Novaerus is a company that offers an airborne pathogen control technology to help improve quality of air. Novaerus scrubs the air using a unique plasma field to reduce airborne pathogens. Novaerus claims its clients can expect lowered re-hospitalizations and decreased antibiotic usage within one year of implementing the Novaerus technology. The technology eradicates all airborne viruses,bacteria, moulds and odours and destroys contaminants like MRSA, C-Diff, Norovirus and Influenza.

Novaerus offers Defend 400 and Defend 1050.

Novaerus has made 1 acquisition, including Plasma Air.

Novaerus has 2 investors. Key investors include Polaris Partners, and F-Prime Capital.

Novaerus operates through Novaerus, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available